Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/1995
11/21/1995US5468773 Treating postmenopausal osteoporosis; side effect reduction
11/21/1995US5468744 Composition comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
11/21/1995US5468736 Hormone replacement therapy
11/21/1995CA1337591C Therapeutic composition comprising oestrogen and antioestrogen
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995EP0682026A1 "Stable crystalline (6S)- and (6R)-tetrahydrofolic acid"
11/15/1995EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method
11/15/1995EP0681582A1 Pyrazole derivatives and pharmaceutical compositions thereof
11/15/1995CN1111630A Adhesion receptor antagonists
11/15/1995CN1111511A Combination treatment for osteoporosis
11/15/1995CN1030253C Methylenebisphosphonic acid derivatives
11/14/1995US5466682 Bone disorders
11/14/1995US5466451 Carbon dioxide, supercritical
11/07/1995US5464862 Method for inhibiting bone loss using centchroman derivatives
11/02/1995WO1995028936A1 Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis
11/02/1995EP0679659A1 Cathepsin-l-specific inhibitor polypeptide
11/02/1995EP0679628A1 Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use
11/02/1995EP0679393A2 Pharmaceutical composition for treating osteoporosis containing xanthohumol
11/02/1995EP0679157A1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
11/02/1995EP0679088A1 Pulmonary delivery of active fragments of parathyroid hormone
11/01/1995CN1110920A Medicament for treatment of hyerosteogeny and its prepn.
11/01/1995CN1110917A Traditional Chinese medicinal film for dispelling wind
10/1995
10/31/1995US5462932 Aqueous, buffered alendronate solution containing a complexing agent to prevent precipitation; bone loss prevention
10/31/1995US5462925 Transforming growth factor β2,3
10/26/1995WO1995028406A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995CA2188172A1 Human bone stimulating factor
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460820 Methods for providing testosterone and optionally estrogen replacement therapy to women
10/22/1995CA2147419A1 Pharmaceutical composition for treating osteoporosis
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027724A1 An equilin double bond isomer from the acid isomerization of equilin
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2186486A1 An equilin double bond isomer from the acid isomerization of equilin
10/18/1995CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110162A Peristrophe japonica liniment and preparation method thereof
10/17/1995US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin
10/12/1995WO1995026984A1 Process for producing composition containing bovine insulin-like growth factor 1
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/11/1995CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
10/10/1995US5457217 Treating bone disorders, osteoporosis
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457117 Method for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B][2-(piperidin-1-yl)ethoxyphenylimethanone hydrochloride
10/04/1995EP0675121A1 Novel intermediates and processes for preparing benzothiophene compounds
10/04/1995EP0674903A1 Raloxifene for inhibiting bone loss and lowing serum cholesterol
10/04/1995EP0674509A1 Methods for treatment with dimercaptosuccinic acid (dmsa)
10/03/1995CA2065093C Remedies for bone diseases
10/01/1995CA2145614A1 Intermediates and processes for preparing benzothiophene compounds
09/1995
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025522A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/26/1995US5453419 Xenopus laevis bone morphogenetic proteins and use thereof
09/21/1995WO1995025273A1 Methods and devices for automatic assessment of corn
09/21/1995WO1995024909A1 Osteoporosis preventing or treating agent
09/20/1995EP0672057A1 Analogs of pth
09/19/1995US5451606 Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment
09/14/1995WO1995024211A1 Use of fibroblast growth factors to stimulate bone growth
09/14/1995WO1995024182A1 Human osteoclast-derived cathepsin
09/14/1995CA2443236A1 Human osteoclast-derived cathepsin
09/13/1995EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same
09/12/1995US5449798 Phospholipid derivatives containing higher elements of the fifth group
09/08/1995WO1995023798A1 Prodrugs of morpholine tachykinin receptor antagonists
09/08/1995WO1995023790A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
09/06/1995EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent
09/03/1995CA2141999A1 Methods of use for inhibiting bone loss and lowering serum cholesterol
08/1995
08/30/1995EP0668879A1 Truncated insulin-like growth factor binding proteins having mitogenic activity
08/29/1995US5446189 Diester intermediates for diacid enzyme inhibitor
08/24/1995WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/23/1995EP0668278A1 Adhesion receptor antagonists
08/20/1995CA2142741A1 Adhesion receptor antagonists
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995CN1106806A Adhesion receptor antagonists
08/16/1995CN1106693A Drug composite for curing bone tuberculosis in fumigation
08/15/1995US5442101 Methylenebisphosphonic acid derivatives
08/15/1995US5441976 Immunostimulants
08/09/1995CN1106401A Novel macrolides and the use thereof
08/09/1995CN1106396A Intermediates useful in the production of aromatic amino-alcohol derivatives having anti-diabetic an21443/o1besity properties
08/09/1995CN1106279A Painless bonesetting medicine
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995CA2182205A1 Human growth hormone
08/02/1995EP0665015A2 Combination treatment for osteoporosis
08/02/1995CN1105882A Parathyroid hormone and raloxifene for increasing bone mass
08/01/1995US5438048 Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation
07/1995
07/29/1995CA2140952A1 Combination treatment for osteoporosis
07/27/1995WO1995014778A3 Dna sequence coding for a bmp receptor
07/26/1995EP0664287A1 Vitamin D Compounds and method of preparing these compounds
07/26/1995CN1105582A Dongfang Qubi Refugao-a hot compress plaster for curing rheumatism
07/25/1995US5436258 Prevention of bone resorption
07/25/1995US5436257 Low toxicity
07/25/1995US5435999 Cytokines for cell proliferation
07/20/1995WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/20/1995WO1995019356A1 Endopeptidase 24.15 inhibitor
07/13/1995WO1995018620A1 Treatment using arachidonic acid metabolite and particulate formulations
07/13/1995WO1995016035A3 Bmp-12, bmp-13 and tendon-inducing compositions thereof
1 ... 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 ... 820